Clinical Trial Transportation

One of the biggest challenges in the medical research and pharmaceutical industry is testing new drugs and their efficacy. The development phase is extensive, but once companies have something that is ready, it still can’t just go on the market. Researchers must conduct numerous tests to see everything that these drugs can do—as well as their potential side effects. This testing phase is also known as the clinical trial phase, and researchers will work with different patients and monitor them to see how the drugs are working and affecting the patients. It’s an important step, but depending on the location of your research lab, your research may be incredibly limited.

At Event Marketing Drivers, we can help you expand your reach with clinical trial transportation. We have a team of experienced drivers who can work with you to deploy decentralized clinical trial (DCT) vehicles across the country. By working together, we can establish mobile clinical trials that can reach underserved markets and collect important data points that can significantly aid in a drug’s development.

Decentralized clinical trials like these can reach communities that need help the most. Event Marketing Drivers has the expertise, and knowledge to handle the DOT transportation elements of accessing these less conventional clinical trial locations. Our drivers will get you across the country and help boost your clinic’s future drug developments, making direct-to-participant trials possible. Relying only on participants who can reach your clinic severely limits your trial’s reach. Many clinics go with this strategy because of necessity, but with Event Marketing Drivers handling clinical trial transportation, your clinics’ impact can be expanded.

Most clinical trials are isolated to a few groups of people, as only people with the time, resources, and geographical availability are the ones participating in the on-site research. However, with Event Marketing Drivers on your side, you can reach a diverse set of patients who can help you obtain more comprehensive and complete data about the drugs you’re developing. Well-rounded research like this will help underserved markets and ensure you can develop high-quality drugs and treatments.